BIOFILCHEM Stock Overview
Biofil Chemicals and Pharmaceuticals Limited se dedica al negocio farmacéutico y químico principalmente en la India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Biofil Chemicals and Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹67.75 |
| 52 Week High | ₹79.00 |
| 52 Week Low | ₹41.30 |
| Beta | 2.39 |
| 1 Month Change | -5.97% |
| 3 Month Change | 16.71% |
| 1 Year Change | 52.42% |
| 3 Year Change | -4.51% |
| 5 Year Change | 791.45% |
| Change since IPO | 195.21% |
Recent News & Updates
Recent updates
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 01
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Shares Climb 60% But Its Business Is Yet to Catch Up
Sep 18
There's Reason For Concern Over Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Price
Sep 03Getting In Cheap On Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM) Is Unlikely
Jul 18Shareholder Returns
| BIOFILCHEM | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 11.8% | 1.1% | 3.2% |
| 1Y | 52.4% | 62.5% | 48.9% |
Rentabilidad frente al sector: BIOFILCHEM obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 65.6%.
Rentabilidad vs. Mercado: BIOFILCHEM superó al mercado Indian, que obtuvo un rendimiento del 46.6% el año pasado.
Price Volatility
| BIOFILCHEM volatility | |
|---|---|
| BIOFILCHEM Average Weekly Movement | 11.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.3% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: BIOFILCHEM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: BIOFILCHEM(10%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de los valores de Indian.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 47 | Ramesh Shah | https://www.biofilgroup.net |
Biofil Chemicals and Pharmaceuticals Limited se dedica al negocio farmacéutico y químico principalmente en la India. La empresa ofrece fármacos y productos químicos básicos, como cloruro sódico, cloruro potásico, citrato sódico, citrato de dietil carbamazina, sulfato ferroso, sulfato ferroso seco, fumerato ferroso, celulosa microcristalina y clorhidrato de diciclomina, así como tapones de plástico. También proporciona servicio de trabajo para la fabricación de productos farmacéuticos.
Biofil Chemicals and Pharmaceuticals Limited Fundamentals Summary
| BIOFILCHEM fundamental statistics | |
|---|---|
| Market cap | ₹1.11b |
| Earnings (TTM) | ₹6.69m |
| Revenue (TTM) | ₹384.48m |
165.5x
P/E Ratio2.9x
P/S RatioIs BIOFILCHEM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOFILCHEM income statement (TTM) | |
|---|---|
| Revenue | ₹384.48m |
| Cost of Revenue | ₹355.96m |
| Gross Profit | ₹28.52m |
| Other Expenses | ₹21.83m |
| Earnings | ₹6.69m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.41 |
| Gross Margin | 7.42% |
| Net Profit Margin | 1.74% |
| Debt/Equity Ratio | 3.2% |
How did BIOFILCHEM perform over the long term?
See historical performance and comparison